/hormone-supplement-overview
Femarelle review and overview: a non-hormonal dietary supplement marketed to support menopausal symptom comfort. Includes product details and evidence summary.

Not medical advice. Speak with a healthcare professional before using any medication.

Efficacy information based on publicly available clinical literature and peer-reviewed research.
Femarelle is a family of non-hormonal, soy-derived menopause support supplements built around a proprietary fermented soy extract (DT56a) combined with vitamins and minerals. According to manufacturer labeling for Femarelle, it is marketed to support symptom comfort associated with hormonal changes, without containing estrogen itself.
Femarelle is a group of three over-the-counter supplement products designed for different life stages: Rejuvenate (perimenopause), Recharge (menopause), and Unstoppable (postmenopause). According to manufacturer labeling for Femarelle, all formulas center on DT56a, a processed soy-derivative marketed to interact with estrogen receptors in a plant-derived way without being an actual hormone. Each product adds specific vitamins targeted to the symptom profile of that stage. Individual responses vary.
Femarelle is marketed as a non-hormonal supplement for women who want symptom support during menopausal changes but prefer not to use prescription hormone therapy or for whom a prescriber has not recommended it. It is sold as a daily capsule taken long-term, similar to most phytoestrogen-based supplement blends. As a non-hormonal dietary supplement under DSHEA, Femarelle works through different mechanisms than prescription hormone therapy. These are different product categories with different evidence bases.
Because it contains no estrogen, Femarelle is not a hormone product. Patients exploring options for menopausal support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Femarelle, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber's clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.

At Voshell’s Pharmacy, we believe in honest guidance — not hype. Visit us in-store or reach out to speak with a pharmacist who knows you and your health.
Contact UsFemarelle is marketed to support mild-to-moderate menopausal symptom comfort, though individual responses vary and effects are not uniform across all users. As a non-hormonal dietary supplement under DSHEA, Femarelle works through different mechanisms than prescription hormone therapy. These are different product categories with different evidence bases.
The main active ingredient in Femarelle is a soy-derived compound called DT56a, which is marketed to behave as a weak selective estrogen receptor modulator-like compound. Per a study indexed on PubMed (PMID 17428655), the available data come from small trials suggesting that Femarelle may be marketed to support:
These effects may be meaningful for individuals who prefer non-prescription options. The overall strength of evidence remains modest — trials are small, not all independently funded, and DT56a is a dietary supplement ingredient with a different mechanism profile than prescription therapies. Individual responses vary considerably.
Patients exploring options for menopausal support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Femarelle, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber's clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.
According to manufacturer labeling for Femarelle, DT56a is a soy-derived compound marketed to act on estrogen receptors. Per a study indexed on PubMed (PMID 17428655), some small trials suggest it may help support vasomotor comfort, including hot flash and night sweat frequency, particularly for individuals who prefer non-prescription options. Individual responses vary.
Per peer-reviewed literature cited on this page, Femarelle may help support sleep quality and mood stability by working through estrogen-related pathways. According to manufacturer labeling for Femarelle, effects are marketed as mild and supportive. Individual responses vary, and a prescriber should assess what options are appropriate for each patient.
Per a study indexed on PubMed (PMID 15958004), early research suggests DT56a may have a supportive effect on bone turnover markers, which may help support bone maintenance over time. According to manufacturer labeling for Femarelle, this is intended as supportive supplementation and is not marketed as a replacement for standard osteoporosis prevention or management. Individual responses vary.
According to manufacturer labeling for Femarelle, it offers a non-prescription option for individuals seeking symptom support without hormone therapy. As a non-hormonal dietary supplement under DSHEA, Femarelle works through different mechanisms than prescription hormone therapy. Per Natural Medicines database, it is generally considered well-tolerated, though individual responses vary and a prescriber should guide any treatment decisions.
You don’t have to figure it out alone. Our pharmacists are available to answer questions and help you make an informed choice, based on your needs.

Femarelle may be a relevant option for individuals who prefer non-hormonal supplements and are seeking support for vasomotor symptoms, sleep quality, mood stability, or perimenopausal discomfort. As a non-hormonal dietary supplement regulated under DSHEA, it works through different mechanisms than prescription hormone therapy and represents a separate product category. A prescriber should determine what approach is most appropriate for each individual.
Per peer-reviewed literature cited on this page, Femarelle products (particularly the DT56a soy-derived compound) may be most useful for individuals who want a plant-based option with a more structured evidence base than many generic menopause blends. Per a study indexed on PubMed (PMID 26455645), available research shows modest support for vasomotor symptom comfort, some sleep quality support, mood stability support, and possible mild vaginal comfort support. These responses tend to be noticeable but not dramatic, and individual variation is substantial.
According to manufacturer labeling for Femarelle, it may be best suited for:
For individuals whose primary concerns are severe vasomotor symptoms, marked sleep disruption, or significant genitourinary symptoms, a prescriber can help assess whether Femarelle or another option is appropriate. Individual responses vary considerably.
Patients exploring options for menopausal support may discuss FDA-approved hormone therapies, lifestyle approaches, dietary supplements such as Femarelle, and (when a prescriber determines appropriate) compounded preparations prepared pursuant to a valid prescription with their healthcare provider. Compounded medications are not FDA-approved and require a prescriber's clinical judgment. A prescriber should determine whether any medication or supplement is appropriate for an individual patient.
Have questions about compounding? Contact Voshell's Pharmacy — we prepare patient-specific medications pursuant to valid prescriptions from your licensed prescriber.
Learn about Femarelle: dosage, side effects, important considerations, and cost for informed conversations with your healthcare provider.
Find out whether you need a prescription for Femarelle, how it works, and the safest way to purchase it.